Peer-Reviewed Publication

Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential

View

Webinar

Picking the Best Antibody Therapeutic Candidates to Develop the Most Effective COVID-19 Therapeutic Cocktail

View

Peer-Reviewed Publication

Presence and Strength of Binding of IgM, IgG and IgA Antibodies Against SARS-CoV-2 During COVID-19 Infection

View

Webinar

Accelerated High-Throughput and High-Content Antibody Discovery Targeting SARS-CoV-2 Spike Protein

View

Webinar

Accelerating Drug Discovery at a Pandemic Pace

View

Application Note

Monitoring Immune Response to SARS-CoV-2

View

Peer-Reviewed Publication

High throughput surface plasmon resonance imaging method for clinical detection of presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during COVID-19 infection

View

Webinar

Develop High Quality Therapeutic Antibodies Straight From Selections in Record Time

View

Webinar

Interview on the Rapid Discovery of SARS-CoV-2 Neutralizing Antibodies

View

Webinar

Surface Plasmon Resonance (SPR) Essentials & Principles of High Throughput Kinetic Analysis – March 19, 2021

View

Peer-Reviewed Publication

Common Light Chain Chickens Produce Human Antibodies of High Affinity and Broad Epitope Coverage for the Engineering of Bispecifics

View

Webinar

The Therapeutic Antibody Revolution in the Post Genomics Era – November 19, 2020

View

Video

Scientist-to-Scientist Series: The discovery of therapeutic antibody cocktails

View

Podcast

Product Launch Labs #1: Developing Value Propositions with Tim Germann

Listen